[1] MORI K,EMOTO M,INABA M.Fetuin-A:a multifunctional protein[J].Recent Pat Endocr Metab Immune Drug Discov,2011,5(2):124-146.
[2] MEHROTRA R.Emerging role for fetuin-A as contributor to morbidity and mortality in chronic kidney disease[J].Kidney Int,2007,72(2):137-140.
[3] TURMEN K,GORGULU N,UYSAL M,et al.Fetuin-A,inflammation,and coronary artery calcification in hemodialysis patients[J].Indian Nephrol,2011,21(2):90-94.
[4] COZZOLINO M,GALASSI A,BIONDI M L,et al.Serum fetuin-A levels link inflammation and cardiovascular calcification in hemodialysis patients[J].Am Nephrol,2006,26(5):423-429.
[5] MOE S M,RESLEROVA M,KETTELER M,et al.Role of calcification inhibitors in the pathogenesis of vascular calcification in chronic kidney disease(CKD)[J].Kidney Int,2005,67(6):2295-2304.
[6] IX J H,BARRETT-CONNOR E,WASSEL C L,et al.The associations of fetuin-A with subclinical cardiovascular disease in community-dwelling persons:the Rancho Bernardo Study[J].Am Coll Cardiol,2011,58(23):2372-2379.
[7] IX J H,KATZ R,de BOER I H,et al.Fetuin-A is inversely associated with coronary artery calcification in community-living persons:the Multi-Ethnic Study of Atherosclerosis[J].Clin Chem,2012,58(5):887-895.
[8] MORI K,IKARI Y,JONO S,et al.Fetuin-A is associated with calcified coronary artery disease[J].Coron Artery Dis,2010,21(5):281-285.
[9] KOOS R,BRANDENBURG V,MAHNKEN A H,et al.Association of fetuin-A levels with the progression of aortic valve calcification in non-dialyzed patients[J].Eur Heart,2009,30(16):2054-2061.
[10] IX J H,CHERTOW G M,SHLIPAK M G,et al.Association of fetuin-A with mitral annular calcification and aortic stenosis among persons with coronary heart disease:data from the Heart and Soul Study[J].Circulation,2007,115(19):2533-2539.
[11] WANG A Y,WOO J,LAM C W,et al.Associations of serum fetuin-A with malnutrition,inflammation,atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients[J].Nephrol Dial Transplant,2005,20(8):1676-1685.
[12] FERRARI G,SAINGER R,BECKMANN E,et al.Validation of plasma biomarkers in degenerative calcific aortic stenosis[J].Surg Res,2010,163(1):12-17.
[13] MORI K,EMOTO M,ARAKI T,et al.Association of serum fetuin-A with carotid arterial stiffness[J].Clin Endocrinol (Oxf),2007,66(2):246-250.
[14] SZEBERIN Z,FEHERVARI M,KREPUSKA M,et al.Serum fetuin-A levels inversely correlate with the severity of arterial calcification in patients with chronic lower extremity atherosclerosis without renal disease[J].Int Angiol,2011,30(5):474-450.
[15] FIORE C E,CELOTTA G,POLITI G G,et al.Association of high alpha2-Heremans-Schmid glycoprotein/fetuin concentration in serum and intima-media thickness in patients with atherosclerotic vascular disease and low bone mass[J].Atherosclerosis,2007,195(1):110-115.
[16] TOUSOULIS D,SIASOS G,MANIATIS K,et al.Novel biomarkers assessing the calcium deposition in coronary artery disease[J].Curr Med Chem,2012,19(6):901-920.
[17] PERTOSA G,SIMONE S,CICCONE M,et al.Serum fetuin a in hemodialysis:a link between derangement of calcium-phosphorus homeostasis and progression of atherosclerosis？[J].Am Kidney Dis,2009,53(3):467-474.
[18] STENVINKEL P,WANG K,QURESHI A R,et al.Low fetuin-A levels are associated with cardiovascular death:impact of variations in the gene encoding fetuin[J].Kidney Int,2005,67(6):2383-2392.
[19] REDDY K J,SINGH M,BANGIT J R,et al.The role of insulin resistance in the pathogenesis of atherosclerotic cardiovascular disease: an updated review[J].Cardiovasc Med (Hagerstown),2010,11(9):633-647.
[20] WANG H,SAMA A E.Anti-inflammatory role of fetuin-A in injury and infection[J].Curr Mol Med,2012,12(5):625-633.
[21] EMOTO M,MORI K,LEE E,et al.Fetuin-A and atherosclerotic calcified plaque in patients with type 2 diabetes mellitus[J].Metabolism,2010,59(6):873-878.
[22] ROOS M,von EYNATTEN M,HEEMANN U,et al.Serum fetuin-A,cardiovascular risk factors,and six-year follow-up outcome in patients with coronary heart disease[J].Am Cardiol,2010,105(12):1666-1672.
[23] MERX M W,SCHAFER C,WESTENFELD R,et al.Myocardial stiffness,cardiac remodeling,and diastolic dysfunction in calcification-prone fetuin-A-deficient mice[J].Am Soc Nephrol,2005,16(11):3357-3364.
[24] REN J,FAVIDOF A J.Alpha2-Heremans Schmid glycoprotein,a putative inhibitor of tyrosine kinase,prevents glucose toxicity associated with cardiomyocyte dysfunction[J].Diabetes Metab Res Rev,2002,18(4):305-310.
[25] 张莉莉,董斌.ESRD非透析患者血清胎球蛋白A水平与左心室结构及功能的关系[J].山东医药,2009,49(13):62-63. |
